A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how fast breast cancers grow in patients and how ...

Long-used imaging strategies such as computed tomography (CT) and bone scintigraphy (BS) to detect lymph node and bone metastases have significant limitations and disadvantages. Newly emerging ...

Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new study. The finding underscores the urgent need for advancements in diagnostic technology ...

The process of staging lung cancer accurately plays a major role in establishing treatment options and predicting survival. Proper lung cancer staging demands a thorough understanding of TNM-8, which ...

DecisionDx-SCC test predicts local recurrence and metastasis in high-risk cutaneous squamous cell carcinoma, enhancing personalized treatment decisions. The test categorizes patients into three risk ...

Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma This is a quality assurance research using nonexperimental design and did ...